SEXI: Mostly Fact, A Little Fiction, Not Vicious Attacks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : SEXI: Mostly Fact, A Little Fiction, Not Vicious Attacks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: telephonics	12/16/2005 8:47:24 AM
	Read Replies (1) of 13351

New SEC FILING ITEM 7.01 REGULATION FD DISCLOSURE Computerized Thermal Imaging, Inc a designer and manufacturer of medical diagnostic equipment utilizing infrared and thermal technologies announced today that they have successfully completed a follow-up audit of their quality management system by VDE/DQS of Germany. The results of the audit included maintenance of certification to ISO 13485:1996 (Standards for Medical Devices), CMDCAS (Canadian Medical Devices Conformity Assessment System) and certification to ANNEX II of the Medical Device Directive (93/42/EEC). Richard Secord, CEO, commented that "this certification to the European and Canadian standards represents a commitment that CTI has to continual improvement and the application of thermal technology in providing healthcare solutions and services worldwide." CTI is continuing to improve their Quality Management System and is now preparing to certify to the latest European and Canadian standards, ISO/CMDCAS 13485:2003. It is expected that this certification will be achieved in the first quarter of 2006. This Current Report on Form 8-K contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Among those risks, trends and uncertainties are CTI's pending application before the FDA seeking pre-market approval of CTI's BCS 2100 breast imaging system, CTI's ability to raise additional capital to fund cash requirements for future operations and CTI's ability to continue as a going concern. In particular, careful consideration should be given to cautionary statements made in the various reports CTI has filed with the Securities and Exchange Commission. CTI undertakes no duty to update or revise these forward-looking statements.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next